Streetbeat News

Earnings

CTV

Innovid has reiterated its full-year 2024 revenue guidance, projecting revenues between $156 million and $163 million, with an estimated midpoint of $160.778 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:46 am

HRMY

Harmony Biosciences (NASDAQ:HRMY) reported Q2 2024 adjusted EPS of $1.05, significantly beating the $(0.06) estimate, and a 38.16% increase from last year. However, sales of $172.814M slightly missed the $173.098M estimate, though they were up 28.76% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:46 am

TGTX

TG Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY24 Briumvi U.S. net product revenue. The company also entered into a term loan facility with Blue Owl Capital.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:45 am

CTV

Innovid expects Q3 revenue to be between $40M and $42M, reflecting a year-over-year growth of 10% to 16%. The estimated revenue is $40.70M.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:45 am

BDTX

Black Diamond Therapeutics reported a Q2 2024 GAAP EPS of $(0.36), missing the estimate of $(0.35).

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:44 am

NERV

Minerva Neurosciences reported a Q2 2024 GAAP EPS of $(1.09), missing the estimate of $(0.73). The company had approximately $31M in cash, cash equivalents, and restricted cash as of June 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:43 am

FWRG

First Watch Restaurant confirms its FY24 total revenue growth of 17.0% to 19.0%, with adjusted EBITDA expected to be between $106.0 million and $112.0 million. The company plans capital expenditures of $125.0 million to $135.0 million, primarily for new restaurant projects and remodels.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:43 am

AU

AngloGold Ashanti shares are trading higher after the company reported a year-over-year increase in H1 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:42 am

KVUE

Kenvue shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:37 am

SGRY

Surgery Partners (NASDAQ:SGRY) reported Q2 earnings of $0.21 per share, beating the analyst estimate of $0.20. Sales were $762.10 million, surpassing the $735.57 million estimate. Despite the earnings beat, EPS decreased by 25% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 11:36 am